Cargando…
Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act
BACKGROUND: Delayed access to care may contribute to disparities in prostate cancer (PCa). The Affordable Care Act (ACA) aimed at increasing access and reducing healthcare disparities, but its impact on timely treatment initiation for PCa men is unknown. METHODS: Men with intermediate‐ and high‐risk...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523962/ https://www.ncbi.nlm.nih.gov/pubmed/37537835 http://dx.doi.org/10.1002/cam4.6419 |
_version_ | 1785110652819341312 |
---|---|
author | Janopaul‐Naylor, James R. Corriher, Taylor J. Switchenko, Jeffrey Hanasoge, Sheela Esdaille, Ashanda Mahal, Brandon A. Filson, Christopher P. Patel, Sagar A. |
author_facet | Janopaul‐Naylor, James R. Corriher, Taylor J. Switchenko, Jeffrey Hanasoge, Sheela Esdaille, Ashanda Mahal, Brandon A. Filson, Christopher P. Patel, Sagar A. |
author_sort | Janopaul‐Naylor, James R. |
collection | PubMed |
description | BACKGROUND: Delayed access to care may contribute to disparities in prostate cancer (PCa). The Affordable Care Act (ACA) aimed at increasing access and reducing healthcare disparities, but its impact on timely treatment initiation for PCa men is unknown. METHODS: Men with intermediate‐ and high‐risk PCa diagnosed 2010–2016 and treated with curative surgery or radiotherapy were identified in the National Cancer Database. Multivariable logistic regression modeled the effect of race and insurance type on treatment delay >180 days after diagnosis. Cochran–Armitage test measured annual trends in delays, and joinpoint regression assessed if 2014, the year the ACA became fully operationalized, was significant for inflection in crude rates of major delays. RESULTS: Of 422,506 eligible men, 18,720 (4.4%) experienced >180‐day delay in treatment initiation. Compared to White patients, Black (OR 1.79, 95% CI 1.72–1.87, p < 0.001) and Hispanic (OR 1.37, 95% CI 1.28–1.48, p < 0.001) patients had higher odds of delay. Compared to uninsured, those with Medicaid had no difference in odds of delay (OR 0.94, 95% CI 0.84–1.06, p = 0.31), while those with private insurance (OR 0.57, 95% CI 0.52–0.63, p < 0.001) or Medicare (OR 0.64, 95% CI 0.58–0.70, p < 0.001) had lower odds of delay. Mean time to treatment significantly increased from 2010 to 2016 across all racial/ethnic groups (trend p < 0.001); 2014 was associated with a significant inflection for increase in rates of major delays. CONCLUSIONS: Non‐White and Medicaid‐insured men with localized PCa are at risk of treatment delays in the United States. Treatment delays have been consistently rising, particularly after implementation of the ACA. |
format | Online Article Text |
id | pubmed-10523962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105239622023-09-28 Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act Janopaul‐Naylor, James R. Corriher, Taylor J. Switchenko, Jeffrey Hanasoge, Sheela Esdaille, Ashanda Mahal, Brandon A. Filson, Christopher P. Patel, Sagar A. Cancer Med RESEARCH ARTICLES BACKGROUND: Delayed access to care may contribute to disparities in prostate cancer (PCa). The Affordable Care Act (ACA) aimed at increasing access and reducing healthcare disparities, but its impact on timely treatment initiation for PCa men is unknown. METHODS: Men with intermediate‐ and high‐risk PCa diagnosed 2010–2016 and treated with curative surgery or radiotherapy were identified in the National Cancer Database. Multivariable logistic regression modeled the effect of race and insurance type on treatment delay >180 days after diagnosis. Cochran–Armitage test measured annual trends in delays, and joinpoint regression assessed if 2014, the year the ACA became fully operationalized, was significant for inflection in crude rates of major delays. RESULTS: Of 422,506 eligible men, 18,720 (4.4%) experienced >180‐day delay in treatment initiation. Compared to White patients, Black (OR 1.79, 95% CI 1.72–1.87, p < 0.001) and Hispanic (OR 1.37, 95% CI 1.28–1.48, p < 0.001) patients had higher odds of delay. Compared to uninsured, those with Medicaid had no difference in odds of delay (OR 0.94, 95% CI 0.84–1.06, p = 0.31), while those with private insurance (OR 0.57, 95% CI 0.52–0.63, p < 0.001) or Medicare (OR 0.64, 95% CI 0.58–0.70, p < 0.001) had lower odds of delay. Mean time to treatment significantly increased from 2010 to 2016 across all racial/ethnic groups (trend p < 0.001); 2014 was associated with a significant inflection for increase in rates of major delays. CONCLUSIONS: Non‐White and Medicaid‐insured men with localized PCa are at risk of treatment delays in the United States. Treatment delays have been consistently rising, particularly after implementation of the ACA. John Wiley and Sons Inc. 2023-08-03 /pmc/articles/PMC10523962/ /pubmed/37537835 http://dx.doi.org/10.1002/cam4.6419 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RESEARCH ARTICLES Janopaul‐Naylor, James R. Corriher, Taylor J. Switchenko, Jeffrey Hanasoge, Sheela Esdaille, Ashanda Mahal, Brandon A. Filson, Christopher P. Patel, Sagar A. Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act |
title | Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act |
title_full | Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act |
title_fullStr | Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act |
title_full_unstemmed | Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act |
title_short | Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act |
title_sort | disparities in time to prostate cancer treatment initiation before and after the affordable care act |
topic | RESEARCH ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523962/ https://www.ncbi.nlm.nih.gov/pubmed/37537835 http://dx.doi.org/10.1002/cam4.6419 |
work_keys_str_mv | AT janopaulnaylorjamesr disparitiesintimetoprostatecancertreatmentinitiationbeforeandaftertheaffordablecareact AT corrihertaylorj disparitiesintimetoprostatecancertreatmentinitiationbeforeandaftertheaffordablecareact AT switchenkojeffrey disparitiesintimetoprostatecancertreatmentinitiationbeforeandaftertheaffordablecareact AT hanasogesheela disparitiesintimetoprostatecancertreatmentinitiationbeforeandaftertheaffordablecareact AT esdailleashanda disparitiesintimetoprostatecancertreatmentinitiationbeforeandaftertheaffordablecareact AT mahalbrandona disparitiesintimetoprostatecancertreatmentinitiationbeforeandaftertheaffordablecareact AT filsonchristopherp disparitiesintimetoprostatecancertreatmentinitiationbeforeandaftertheaffordablecareact AT patelsagara disparitiesintimetoprostatecancertreatmentinitiationbeforeandaftertheaffordablecareact |